Ventyx Biosciences Inc. (VTYX)

NASDAQ: VTYX · Real-Time Price · USD

1.45

0.07 (5.07%)

At close: May 02, 2025, 3:59 PM

1.46

0.69%

After-hours: May 02, 2025, 04:13 PM EDT

Ventyx Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-135.12M	-192.96M	-108.43M	-83.75M	-28.17M	-4.33M
Depreciation & Amortization	1.35M	941K	470K	30K	n/a	n/a
Stock-Based Compensation	22.93M	28.59M	16.57M	2.73M	45K	198K
Other Working Capital	-7.92M	6.55M	-6.77M	1.57M	221K	230K
Other Non-Cash Items	-9.47M	-8.89M	-2.23M	38.32M	21.12M	896K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-10.56M	5.81M	-5.16M	4.02M	812K	591K
Operating Cash Flow	-130.87M	-166.52M	-98.77M	-38.65M	-6.2M	-2.64M
Capital Expenditures	-241K	-514K	-275K	-262K	n/a	n/a
Cash Acquisitions	n/a	n/a	74.66K	1.9M	n/a	n/a
Purchase of Investments	-283.65M	-272.27M	-347.24M	-232.5M	n/a	n/a
Sales Maturities Of Investments	268.38M	373.73M	272.58M	16.5M	n/a	n/a
Other Investing Acitivies	n/a	n/a	-74.66K	-216K	n/a	n/a
Investing Cash Flow	-15.51M	100.94M	-74.93M	-214.37M	n/a	n/a
Debt Repayment	n/a	n/a	n/a	450K	6.13M	2.95M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	466K	4.92M	2.37M	65K	2K	1K
Financial Cash Flow	122.11M	53.33M	167.77M	323.55M	6.13M	2.95M
Net Cash Flow	-24.32M	-12.27M	-5.97M	70.55M	-65K	309K
Free Cash Flow	-131.11M	-167.04M	-99.05M	-38.91M	-6.2M	-2.64M